Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Neoplasms of the CNS

Free Subscription 23.03.2026 1 AJNR Am J Neuroradiol 1 Am J Clin Oncol 3 BMC Cancer 2 Cancer Res 6 Childs Nerv Syst 1 Clin Cancer Res 1 Int J Cancer 5 Int J Radiat Oncol Biol Phys 6 J Neurooncol 2 J Neurosurg 1 J Nucl Med 6 Neuro Oncol 1 Neurol Res 1 Neurology 2 Neuroradiology 2 Neurosurgery 1 Pediatr Neurosurg 2 PLoS One 3 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. TALEKAR K, Naghizadehkashani S, Mohamed F, Jain N, et al
   Impact of Preoperative fMRI and DTI on Neurosurgical Planning for Brain Tumors: A Multi-Institutional Survey Study.
   AJNR Am J Neuroradiol. 2026 Mar 18:ajnr.A9300. doi: 10.3174/ajnr.A9300.
   PubMed         Abstract available
   
   

   
   Am J Clin Oncol

2. BROWN MH, Cherng HR, Assif JW, Sun K, et al
   Conditional Survival Estimates for Malignant Glioma Patients: Secondary Analysis of RTOG 9006.
   Am J Clin Oncol. 2026 Mar 19. doi: 10.1097/COC.0000000000001296.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. BALCI TOPUZ B, Ozturk Iyilikci M
   CALLY index provides improved prognostic stratification compared with other inflammation-based scores in glioblastoma treated with the stupp protocol.
   BMC Cancer. 2026 Mar 20. doi: 10.1186/s12885-026-15852.
   PubMed        
   
   
4. LI J, Tai Y, Pan B, Xiang L, et al
   Efficacy and prognostic factors of stereotactic radiosurgery versus whole-brain radiotherapy for brain metastases in small cell lung cancer: a systematic review and meta-analysis.
   BMC Cancer. 2026 Mar 18. doi: 10.1186/s12885-026-15871.
   PubMed        
   
   
5. HUANG J, Wang Q, Chen Y, Lin C, et al
   Regulatory mechanisms and functional analysis of cellular senescence-associated genes GAPDH, CCND1, and HBEGF in the immune microenvironment of meningioma.
   BMC Cancer. 2026 Mar 17. doi: 10.1186/s12885-026-15593.
   PubMed        
   
   

   
   Cancer Res

6. VALLEBUONA EJ, Smalley I
   Spatially Resolved Opto-Omics Uncovers Functional Microglial Subtypes in Brain Metastasis.
   Cancer Res. 2026;86:1345-1346.
   PubMed         Abstract available
   
   
7. TSUJI T, Hirose H, Sugiyama D, Shindo M, et al
   Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells.
   Cancer Res. 2026;86:1414-1434.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

8. CAVALHEIRO S, Quiroz JAR, Dastoli PA, Kim IHT, et al
   Pilocytic astrocytoma surgery via the pineal region in a 9-year-old boy via the infratentorial-supracerebellar approach.
   Childs Nerv Syst. 2026;42:124.
   PubMed         Abstract available
   
   
9. AHMED S, Abdullah M, Batool S, Fatima H, et al
   Diagnostic challenges and treatment barriers in the management of diffuse intrinsic pontine glioma in low- and lower-middle-income countries: a systematic review.
   Childs Nerv Syst. 2026;42:112.
   PubMed         Abstract available
   
   
10. LIN W, Qiu Y, Ma Z, Yuan H, et al
    Mammosomatotroph pituitary neuroendocrine tumour in a 7-year-old boy: case report.
    Childs Nerv Syst. 2026;42:123.
    PubMed         Abstract available
    
    
11. LIU K, Wang X, Zhang S, Feng S, et al
    Diagnosis, treatment, and postoperative follow-up of intracranial Ewing sarcoma (EWS): a case report.
    Childs Nerv Syst. 2026;42:118.
    PubMed         Abstract available
    
    
12. VITULLI F, Berardinelli J, Bove I, Lorenzetti M, et al
    Surgical management of pediatric pineal region tumors: an overview of current strategies.
    Childs Nerv Syst. 2026;42:117.
    PubMed         Abstract available
    
    
13. MASUMOTO A, Hirotsu T, Nonaka Y, Murayama Y, et al
    Large terminal syringomyelia associated with terminal lipoma: mid- to long-term outcomes after tethered cord release.
    Childs Nerv Syst. 2026;42:111.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

14. SANVITO F, Raymond C, Telesca D, Yao J, et al
    Framework for statistical parametric mapping of the interactions between glioblastoma location, treatment, prognostic variables, and survival using a phase III trial.
    Clin Cancer Res. 2026 Mar 16. doi: 10.1158/1078-0432.CCR-25-4419.
    PubMed         Abstract available
    
    

    
    Int J Cancer

15. GUTZMER R, Weichenthal M, Eigentler T, Mohr P, et al
    Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study.
    Int J Cancer. 2026 Mar 15. doi: 10.1002/ijc.70440.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

16. JABLONSKA PA, Serrano D, Galan N, Barranco J, et al
    A New Predictive Model for Radiation Necrosis Risk based on PTV-enriched Blood Inflammatory Biomarkers in Patients with Brain Metastases Treated with Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2026 Mar 12:S0360-3016(26)00488.
    PubMed         Abstract available
    
    
17. AZNAR MC, Davey A, Wilson LJ, Osorio EV, et al
    Cognitive outcomes after radiotherapy for medulloblastoma: a voxel-based analysis.
    Int J Radiat Oncol Biol Phys. 2026 Mar 12:S0360-3016(26)00492.
    PubMed         Abstract available
    
    
18. SLEVIN F, Chen XS, Rosen BS, Shen CJ, et al
    Constraints, cumulative doses and toxicity outcomes in glioma reirradiation: a systematic review and radiobiological comparison from the Reirradiation Collaborative Group (ReCog).
    Int J Radiat Oncol Biol Phys. 2026 Mar 12:S0360-3016(26)00486.
    PubMed         Abstract available
    
    
19. GUI C, Jenabi M, Daly J, Gillick C, et al
    Functional Magnetic Resonance Imaging-Guided Stereotactic Radiosurgery to Avoid Symptomatic Radionecrosis.
    Int J Radiat Oncol Biol Phys. 2026;124:1186-1198.
    PubMed         Abstract available
    
    
20. AKHAVAN-SIGARI A, Sbaih O, Hori YS, Mathieu D, et al
    Perilesional Edema as a Predictor of Local Failure in Metastatic Brain Lesions Treated With Stereotactic Radiosurgery: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2026;124:1199-1207.
    PubMed         Abstract available
    
    

    
    J Neurooncol

21. NADEL JL, Gamboa NT, Botros D, Crabb BT, et al
    Lower-grade glioma imaging volumes and survival: a single-institution analysis of 90 patients after resection using intraoperative MRI.
    J Neurooncol. 2026;177:63.
    PubMed         Abstract available
    
    
22. LU Y, Cao J, Liu X, Wang H, et al
    The predictive value of serum neurofilament light chain combined with inflammatory biomarkers for post-surgical epilepsy after brain tumor resection: a retrospective diagnostic study.
    J Neurooncol. 2026;177:61.
    PubMed        
    
    
23. CHEHADE R, Al-Humiqani A, Hanna L, Sahgal A, et al
    Brain metastases among patients with gynecologic cancers: a single-centre retrospective study of patients treated with brain radiotherapy.
    J Neurooncol. 2026;177:58.
    PubMed        
    
    
24. SARKAR MM, Gonsalves N, Davarzani A, Mitchell E, et al
    Disrupting Akt-Wnt/beta-catenin signaling suppresses glioblastoma stem cell growth and tumor progression in immunocompetent mice.
    J Neurooncol. 2026;177:56.
    PubMed         Abstract available
    
    
25. BINDAL S, Gonzalez B, Dono A, Riascos R, et al
    Patterns of failure following stereotactic radiosurgery salvage for recurrent high-grade glioma.
    J Neurooncol. 2026;177:55.
    PubMed         Abstract available
    
    
26. ELIA A, Roux A, Demasi M, Debacker C, et al
    Neurocognitive functioning, seizure control, and return to work after awake surgery with or without adjuvant therapy in IDH-mutant grade 3 diffuse gliomas.
    J Neurooncol. 2026;177:53.
    PubMed        
    
    

    
    J Neurosurg

27. HONEYMAN SI, Akhbari M, Voets NL, Stacey R, et al
    Speech mapping in awake high-grade glioma resection: subcortical tract proximity as a predictor of language outcomes.
    J Neurosurg. 2026 Mar 13:1-11. doi: 10.3171/2025.10.JNS251541.
    PubMed         Abstract available
    
    
28. DUNAS T, Jensdottir M, Solheim O, Corell A, et al
    Epidemiology of ischemic lesions after diffuse low-grade glioma resection: a Scandinavian multicenter study.
    J Neurosurg. 2026 Mar 13:1-11. doi: 10.3171/2025.10.JNS25658.
    PubMed         Abstract available
    
    

    
    J Nucl Med

29. LI EJ, Kraya A, Costa-Pinheiro P, Scheuermann J, et al
    Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.
    J Nucl Med. 2026 Mar 19:jnumed.125.271476. doi: 10.2967/jnumed.125.271476.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

30. PUROW B
    A dangerous chip off the old block promoting brain metastasis in inflammatory breast cancer.
    Neuro Oncol. 2026 Mar 13:noag049. doi: 10.1093.
    PubMed        
    
    
31. FU M, Feng Y, Sun P, You M, et al
    DNA Methylation Profiling Reveals a Novel Subtype Harboring IDH Mutation in H3-altered Gliomas.
    Neuro Oncol. 2026 Mar 14:noag054. doi: 10.1093.
    PubMed         Abstract available
    
    
32. LIN J, Liang L, Zhu X, Liu J, et al
    RGS2 Promotes Brain Metastasis of Cisplatin-resistant Non-small Cell Lung Cancer through Caspase-1/IL-1beta Signaling Pathway.
    Neuro Oncol. 2026 Mar 14:noag055. doi: 10.1093.
    PubMed         Abstract available
    
    
33. JANGDE N, Lee MH, Ruiz L, Egan I, et al
    RAC1 Regulates SHH-Medulloblastoma Growth via GLI-Mediated Transcription.
    Neuro Oncol. 2026 Mar 19:noag057. doi: 10.1093.
    PubMed         Abstract available
    
    
34. TONG T, Hendriksen JD, Elbaek KJ, Molnar K, et al
    Combined Patch-clamp Electrophysiology and Single-Cell Genomic Analysis Reveal Spiking Tumor Cells at the Neocortical Glioblastoma Interface in Humans.
    Neuro Oncol. 2026 Mar 19:noag059. doi: 10.1093.
    PubMed         Abstract available
    
    
35. PANG YC, Wang C, Qiu JF, Chen HX, et al
    Targeting tumor-associated macrophages-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization.
    Neuro Oncol. 2026 Mar 19:noag058. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurol Res

36. DING C, Xu Y, Guo Q, Qian Z, et al
    Peroxidasin promotes malignant progression by enhancing glycolytic metabolism in glioblastoma through the regulation of LDHA.
    Neurol Res. 2026 Mar 17:1-15. doi: 10.1080/01616412.2026.2647415.
    PubMed         Abstract available
    
    

    
    Neurology

37. MULLER KJ, Karschnia P, Kaulen LD, Reis J, et al
    Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features.
    Neurology. 2026;106:e214744.
    PubMed         Abstract available
    
    

    
    Neuroradiology

38. STANSKI M, Goralewski M, Watorek J, Antczak S, et al
    Contra-lesional hippocampus in low grade glioma patients with no hippocampal infiltration - a study of structural remodelling.
    Neuroradiology. 2026 Mar 16. doi: 10.1007/s00234-026-03958.
    PubMed        
    
    
39. ZUO X, Ruan Y, Che Z, Yang J, et al
    Vascular permeability mediates contralateral glymphatic dysfunction across glioma grades and IDH status.
    Neuroradiology. 2026 Mar 19. doi: 10.1007/s00234-026-03963.
    PubMed        
    
    

    
    Neurosurgery

40. MALDONADO J, Patel B, Ma T, Zohdy YM, et al
    Comprehensive Comparison of Visual Outcomes in Macro and Giant Prolactinoma Cohorts Managed With Medical Versus Surgical Treatment.
    Neurosurgery. 2025 Aug 6. doi: 10.1227/neu.0000000000003667.
    PubMed         Abstract available
    
    
41. DAYYANI M, Filippov A, Zhang I, Georges J, et al
    RAGE Inhibition Reduces Surgery-Induced Cerebral Edema After Glioma Resection.
    Neurosurgery. 2026 Mar 19. doi: 10.1227/neu.0000000000003987.
    PubMed         Abstract available
    
    

    
    Pediatr Neurosurg

42. SHIMONY N, Weatherspoon S, Hanzlik E, Khan RB, et al
    State of the art management of children with intractable epilepsy and brain tumors.
    Pediatr Neurosurg. 2026 Mar 17:1-32. doi: 10.1159/000551567.
    PubMed         Abstract available
    
    

    
    PLoS One

43. LIU B, Peng D, Chen Y, Li Q, et al
    Multi-omics analysis identifies CCNB1 as a cell cycle factor driving glioblastoma progression and its inhibition by resveratrol.
    PLoS One. 2026;21:e0344872.
    PubMed         Abstract available
    
    
44. NAKAO S, Uemichi Y, Nagano S, Mabuchi M, et al
    Effect of anticancer activity of aripiprazole main metabolite OPC-14857 on malignant glioblastoma.
    PLoS One. 2026;21:e0338895.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

45. CHEN X, Zhong X, Yue W, Wang B, et al
    A transcription regulator atlas identifies TOX3 as an Atoh1 coactivator in cerebellar development and tumorigenesis.
    Proc Natl Acad Sci U S A. 2026;123:e2527163123.
    PubMed         Abstract available
    
    
46. BILLINGHAM LK, DeLay SL, Eshac Y, Chia TY, et al
    Microglial fructose metabolism is essential for glioblastoma growth.
    Proc Natl Acad Sci U S A. 2026;123:e2521256123.
    PubMed         Abstract available
    
    
47. FU Z, Zhao X, Zhang Q, Han M, et al
    Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma.
    Proc Natl Acad Sci U S A. 2026;123:e2519819123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum